NCT06871176View on ClinicalTrials.gov

PET/MR Scan With [68Ga]Ga-PentixaFor (CXCR4) vs Standard of Care (SOC) for Initial Staging and Follow up in Multiple Myeloma (MM)

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 22, 2025

Primary Completion Date

March 4, 2028

Study Completion Date

March 4, 2028

Conditions

Multiple Myeloma

Interventions

DRUG

[68Ga]Ga-PentixaFor

\[68Ga\]Ga-PentixaFor will be administered intravenously using the recommended activity for adults which is up to 150 MBq (4 mCi) fixed dose. There is no weight adaption recommended in the literature.

Trial Locations (1)

M5G 2N2

RECRUITING

University Health Network, Toronto

All Listed Sponsors

lead

University Health Network, Toronto

OTHER